C-Reactive protein and cardiovascular risk: has the time come for screening the general population?
Koenig, W.
Clinical Chemistry 47(1): 9-10
2001
ISSN/ISBN: 0009-9147 PMID: 11148168 Document Number: 535575
Document emailed within 1 workday
Related Documents
Heald, A.H. 2007: Subclinical inflammation, C-reactive protein and cardiovascular risk Indian Journal of Medical Research 125(4): 502-504Snežana Jovičić; Ignjatovi, S.ć; Dajak, M.; Kangrga, R.; Majki, N.ć-Singh 2009: Association of Lipid and Inflammatory Markers with C-Reactive Protein in Cardiovascular Risk Assessment for Primary Prevention Clinical Laboratory 55(11-12): 411-419
Engberg, M.; Christensen, B.; Karlsmose, B.; Lous, Jørgen.; Lauritzen, T. 2002: Can systematic general health screening and patient-physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5-year follow-up Ugeskrift for Laeger 164(25): 3354-3360
Olszewski, R.; Grabysa, R.ła.; Warmiński, J.; Makowski, T.; Szczechowicz, R.; Piechota, W.; Adamus, J. 2002: C-reactive protein as a new risk factor of coronary heart disease in the population of young Polish males Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(73): 14-17
Bansal, M.; Shrivastava, S.; Mehrotra, R.; Agrawal, V.; Kasliwal, R.R. 2009: Time-trends in prevalence and awareness of cardiovascular risk factors in an asymptomatic North Indian urban population Journal of the Association of Physicians of India 57: 568-573
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Stevermer, J.J. 2003: Does C-reactive protein predict cardiovascular events in women better than LDL? Journal of Family Practice 52(3): 185-186
Viseshakul, D.; Chaivatsu, C.; Soonthornsima, P.; Chularojanamontri, V.; Premwatana, P.; Kewsiri, D.; Chuprasert, S. 1979: Health screening survey to determine risk factors of cardiovascular diseases in a selected Thai population: a study in 1 331 Thai government savings bank clerks Journal of the Medical Association of Thailand 62(10): 550-560
Hansen, J.G.; Dahler-Eriksen, B.S. 2000: C-reactive protein and infections in general practice Ugeskrift for Laeger 162(17): 2457-2460
Wong, M.S. 2006: Health screening packages: the place of measuring C-reactive protein Singapore Medical Journal 47(10): 827-829
Palmieri, L.; Trojani, M.; Vanuzzo, D.; Panico, S.; Pilotto, L.; Dima, F.; Noce, C.L.; Uguccioni, M.; Pede, S.; Giampaoli, S. 2005: Distribution of the global cardiovascular risk in the Italian population: results from the cardiovascular epidemiologic observatory Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 6(5): 279-284
Oksa, A. 2006: Cardiovascular risk in patients with chronic kidney diseases: a time for new risk markers? Bratislavske Lekarske Listy 107(8): 314-319
van Asperen, C.J.; de Bock, G.H.; van der Horst, F.; de Koning, H.J.; Rutgers, E.J. 2001: Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program Nederlands Tijdschrift Voor Geneeskunde 145(3): 120-125
Baptista-González, H.A.; Maciel-Corrales, A.L.; Ibarra-Camacho, A.; Lozano-González, C. 1989: Determination of C-reactive protein in low-risk newborn infants Boletin Medico del Hospital Infantil de Mexico 46(7): 482-484
Yogesh M. Shastr 2008: Prospective Comparative Evaluation of an Office-Based Rapid Immunological Test with a Guaiac-Based Fecal Occult Blood Test for Colorectal Cancer Screening in General Population with Average-Risk Clinical Laboratory 54(9-10): 385-387
Dahler-Eriksen, B.S.; Lassen, J.F.; Lauritzen, T.; Lund, E.D.; Brandslund, I. 1998: Differences in the use of C-reactive protein analysis and erythrocyte sedimentation in general practice and hospitals. Development from 1986 to 1995 Ugeskrift for Laeger 160(34): 4868-4872
Hui, L.; Yuai, W.; Xia, Q.; Hong, Y. 2010: Serum Glucose- and C-Reactive Protein-Based Assessment of Stress Status in a Healthy Population Clinical Laboratory 56(5-6): 227-230
Racek, J.; Racková, M. 2002: Less common risk factors for atherogenesis--homocysteine, lipoprotein (a) and C-reactive protein Casopis Lekaru Ceskych 141(19): 605-609
Cheng, J.; Zhao, D.; Wang, W.; Sun, J.-Y.; Wu, Z.-S. 2007: Study on the interaction between C-reactive protein and hypertension on the risk of carotid plaque Zhonghua Liu Xing Bing Xue Za Zhi 28(12): 1211-1214
Mathai, E.; Christopher, U.; Mathai, M.; Jana, A.K.; Rose, D.; Bergstrom, S. 2004: Is C-reactive protein level useful in differentiating infected from uninfected neonates among those at risk of infection? Indian Pediatrics 41(9): 895-900